Cargando…
Modeling the Cost Effectiveness of Neuroimaging-Based Treatment of Acute Wake-Up Stroke
BACKGROUND: Thrombolytic treatment (tissue-type plasminogen activator [tPA]) is only recommended for acute ischemic stroke patients with stroke onset time <4.5 hours. tPA is not recommended when stroke onset time is unknown. Diffusion-weighted MRI (DWI) and fluid attenuated inversion recovery (FL...
Autores principales: | Pandya, Ankur, Eggman, Ashley A., Kamel, Hooman, Gupta, Ajay, Schackman, Bruce R., Sanelli, Pina C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740488/ https://www.ncbi.nlm.nih.gov/pubmed/26840397 http://dx.doi.org/10.1371/journal.pone.0148106 |
Ejemplares similares
-
Cost-Consequence Analysis of Advanced Imaging in Acute Ischemic Stroke Care
por: Boltyenkov, Artem T., et al.
Publicado: (2021) -
Cost Effectiveness of Assessing Ultrasound Plaque Characteristics to Risk Stratify Asymptomatic Patients With Carotid Stenosis
por: Baradaran, Hediyeh, et al.
Publicado: (2019) -
Neuroimaging of Meckel’s cave in normal and disease conditions
por: Malhotra, Ajay, et al.
Publicado: (2018) -
International Survey on the Management of Wake-Up Stroke
por: de Castro-Afonso, Luís Henrique, et al.
Publicado: (2016) -
Patent foramen ovale and wake-up stroke
por: van der Boon, Robert M A, et al.
Publicado: (2021)